Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Generic Manufacturers Face Uphill Climb After Federal Circuit’s ‘Skinny Label’ Decision
Feb 15 2022
•
By
Brenda Sandburg
Appeals court declines to rehear 'skinny label' case on generic label carve-outs • Source: Alamy
More from Generics
More from Biosimilars & Generics